Summary & Overview
CPT 93597: Diagnostic Cardiac Catheterization for Congenital Heart Defects
CPT code 93597 designates an invasive diagnostic cardiac catheterization performed for patients born with one or more congenital heart defects and abnormal native connections, where catheters are advanced to both right and left heart chambers to obtain blood gas samples and hemodynamic measurements. This code is clinically important for confirming physiologic shunts, pressure gradients, and oxygenation in complex congenital heart disease and guides management decisions including surgical or catheter-based interventions.
Key national payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise technical description of the procedure, typical sites of service, and the clinical context in which CPT code 93597 is used. The publication summarizes common billing modifiers applicable to cardiac catheterization and outlines expected documentation elements and service components.
The analysis presents benchmarking context and policy-relevant points for payers and health systems, including utilization patterns, clinical indications, and how this diagnostic service interfaces with subsequent interventional or surgical care. Data not available in the input is identified where applicable.
Billing Code Overview
CPT code 93597 describes catheter-based diagnostic sampling in patients born with congenital heart defects and abnormal native connections. The procedure involves navigating one or more catheters through the vasculature to the heart, placing catheter(s) into both the right and left sides, and obtaining blood samples to measure blood gases; additional hemodynamic measurements may be performed during the same encounter.
-
Service type: Invasive diagnostic cardiac catheterization with bilateral heart sampling
-
Typical site of service: Hospital inpatient or hospital outpatient catheterization laboratory or cardiac catheterization suite
Clinical & Coding Specifications
Clinical Context
A neonate or infant with known congenital heart disease (for example, septal defects, transposition of the great arteries, tetralogy of Fallot, single ventricle physiology, or anomalous pulmonary venous return) is brought to the cardiac catheterization laboratory for invasive hemodynamic assessment. The patient arrives from the pediatric cardiology inpatient unit or the newborn nursery after echocardiography and clinical exam suggest complex intracardiac shunting or abnormal native connections requiring definitive physiologic measurement. Under general anesthesia or deep sedation, pediatric interventional cardiology and anesthesia teams perform vascular access (typically femoral venous and arterial), advance catheters to right- and left-sided cardiac chambers and great vessels, and obtain oximetry runs and blood gas samples. Pressures are recorded (right atrial, right ventricular, pulmonary artery, pulmonary capillary wedge when applicable, left atrial/ventricular), and calculations such as pulmonary-to-systemic flow ratio (Qp:Qs) and indexed vascular resistances are performed to guide surgical or transcatheter planning. The procedure may be diagnostic alone or combined with interventional steps; per the code description, sampling and measurements are the primary billed activity. Typical site of service is an inpatient or outpatient hospital-based cardiac catheterization laboratory with pediatric interventional cardiology capabilities. Expected clinical workflow includes pre-procedure consent and imaging review, anesthesia induction, catheter navigation to both right and left heart chambers, specimen collection and hemodynamic measurements, and post-procedure recovery with monitoring for vascular complications or arrhythmia.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|